Treatment of Chronic MRSA Colonization
For chronic MRSA colonization, the recommended treatment is a combination of intranasal mupirocin 2% ointment applied twice daily for 5 days with chlorhexidine gluconate body washes or dilute bleach baths. 1
Decolonization Protocol
First-Line Approach
Nasal Decolonization:
Body Decolonization (choose one):
Special Considerations
- Pre-operative decolonization: Strongly recommended before cardiac and orthopedic surgery (complete 1-2 weeks before surgery) 2
- Household members: Consider evaluating and decolonizing household contacts to prevent recolonization 2, 1
- Site-specific colonization:
Monitoring and Follow-up
Duration of follow-up: Monitor for at least 270 days after decolonization, as 88% of recurrences occur within this timeframe 4
Effectiveness assessment:
Risk factors for decolonization failure:
Management of Persistent Colonization
If initial decolonization fails despite good adherence:
Repeat decolonization cycle: Consider up to 2-3 cycles before changing approach 3
Consider oral antibiotics (only after topical measures have failed):
Maintenance therapy for recurrent infections:
- Monthly 5-day courses of mupirocin (can reduce recurrent infections by ~50%) 1
Environmental and Hygiene Measures
Personal hygiene:
Environmental cleaning:
Personal items:
Pitfalls and Caveats
Mupirocin resistance: Increasing rates of resistance have been reported; consider susceptibility testing if available 1
Oral antibiotics: Not routinely recommended for decolonization due to risk of developing resistance and adverse effects 2, 1
Chlorhexidine sensitivity: Monitor for skin irritation or allergic reactions 1
Bleach baths: Provide clear dilution instructions to prevent skin irritation 2
Incomplete decolonization: Failure to address all colonized sites may lead to persistent colonization 3
Household transmission: Failure to address household contacts may result in recolonization 6
The evidence strongly supports a structured approach to MRSA decolonization, with the highest quality evidence supporting the combination of intranasal mupirocin and topical antiseptics. This approach has demonstrated significant reductions in MRSA colonization and subsequent infection risk, particularly in high-risk populations such as pre-surgical patients.